Display options
Share it on

J Clin Exp Dent. 2016 Oct 01;8(4):e368-e372. doi: 10.4317/jced.52540. eCollection 2016 Oct.

Effectiveness of Amlexanox and Adcortyl for the treatment of recurrent aphthous ulcers.

Journal of clinical and experimental dentistry

Farid Abbasi, Maryam Raoof, Roya Khatami, Niloofar Shadman, Farnaz Borjian-Boroojeni, Farahnaz Nazari

Affiliations

  1. Associate Professor. Department of Oral Medicine, School of Dentistry, Shahed University of Medical Sciences, Tehran, Iran.
  2. Assistant Professor. Laboratory of Molecular Neuroscience, Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
  3. Postgraduate Student of Oral Medicine. School of Dentistry, Shahed University, Tehran, Iran.
  4. Assistant Professor. Department of Operative Dentistry, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran.
  5. Department of Oral Medicine, School of Dentistry, Shahed University, Tehran, Iran.
  6. Postgraduate Student of Endodontics. School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran.

PMID: 27703603 PMCID: PMC5045682 DOI: 10.4317/jced.52540

Abstract

BACKGROUND: Recurrent aphthous stomatitis (RAS) is a common condition that affects approximately 20% of the general population. The ulcers can interfere with speech and eating and cause significant pain and discomfort. This study aimed to evaluate the efficacy of Amlexanox and Adcortyl in the treatment of aphthous ulcers.

MATERIAL AND METHODS: In this randomized double blind clinical trial with sequential patient entry, a total of 40 patients who presented with aphthous ulcers were included. Patients were received Amlexanox or Adcortyl four times daily for 7 days. Patients were evaluated for pain, lesion size, and tingling at one day, three days, five days and seven days follow-ups. The treatment effects were then evaluated using the Wilcoxon-Mann-Whitney (WMW) test. Values of

RESULTS: No significant differences in pain score, tingling and lesion size were observed on similar days between Amlexanox and Adcortyl groups. In both groups, reduction in the assessed variables was significant between days 1-3, 3-5, and 5-7 (

CONCLUSIONS: This study indicated that Amlexanox as well as Adcortyl was effective in relieving pain and reducing the lesion size during the treatment of aphthous ulcers.

Conflict of interest statement

The authors deny any conflicts of interest related to this study.

References

  1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):475-81 - PubMed
  2. Oral Dis. 2011 Nov;17(8):755-70 - PubMed
  3. J Oral Pathol Med. 2006 Feb;35(2):117-22 - PubMed
  4. Trials. 2009 May 06;10:30 - PubMed
  5. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Feb;83(2):231-8 - PubMed
  6. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Feb;83(2):222-30 - PubMed
  7. Ann Acad Med Singapore. 2012 Oct;41(10):463-70 - PubMed
  8. J Clin Exp Dent. 2014 Apr 01;6(2):e168-74 - PubMed
  9. Indian J Dent Res. 2013 Sep-Oct;24(5):593-8 - PubMed
  10. Oral Surg Oral Med Oral Pathol. 1992 Jul;74(1):79-86 - PubMed
  11. Clin Drug Investig. 2005;25(9):555-66 - PubMed
  12. J Am Dent Assoc. 2003 Feb;134(2):200-7 - PubMed
  13. J Psychiatry Neurosci. 2011 Mar;36(2):87-113 - PubMed
  14. Am J Health Syst Pharm. 2001 Jan 1;58(1):41-50; quiz 51-3 - PubMed
  15. Acta Pharm. 2011 Jun;61(2):157-70 - PubMed
  16. J Oral Pathol Med. 2012 Sep;41(8):577-83 - PubMed
  17. Oral Oncol. 2004 Feb;40(2):158-63 - PubMed
  18. J Oral Pathol Med. 2005 Aug;34(7):413-9 - PubMed
  19. J Clin Diagn Res. 2014 Feb;8(2):218-21 - PubMed
  20. Compend Contin Educ Dent. 1997 Nov;18(11):1116-8, 1120-2, 1124 passim - PubMed
  21. Int J Oral Maxillofac Surg. 2004 Apr;33(3):221-34 - PubMed
  22. J Oral Maxillofac Surg. 1993 Mar;51(3):243-8; discussion 248-9 - PubMed

Publication Types